Table 2 Intervention characteristics of the included studies.
Study | Intervention treatment | Comparison treatment | Sample size (n) | Treatment period | Shift work period | Measure period |
---|---|---|---|---|---|---|
Babkoff 2002 | BL and caffeinea | DL and caffeine | EG: 6 CG: 6 | 2330–0230c | 1730–0830f,h | 0130–0430 |
Bjorvatn 2007 | BLb | Placebo capsules | EG: 17 CG: 17 | 0000–0500 and 1200–1430c | 0630–1830 and 1830–0630g | Every 2 h from 2000 and so on |
Bjorvatn 2020 | BL | DL | EG: 35 CG: 35 | 0200–0300, 0300–0400, 0400–0500 | 2200–0600 | every 2 h at 2200–0600 |
Boivin 2012 | Intermittent BLa | No | EG: 8 CG: 9 | 6 h from 2200, 2230, 2300, or 2330c | 8/8.5 h between 2200–0800f | Every 2 h (phase shift) or every 30 min (sleepiness) at 0600–2200 |
Comtet 2019 | BL | DL | EG: 18 CG: 18 | 0500–0530 | 2000–0800 | 0300, 0500, 0700, 0800 |
Dawson 1991 | BL and DLa | DL | EG: 6 CG: 7 | 2400–0400c | 2300–0700f,h | 0100, 0300, 0500, and 0700 |
Dawson 1995 | BLa | DL | EG: 8 CG: 8 | 2400–0400c | 2300–0700f,h | At night |
Griepentrog 2018 | BL | SL | EG: 26 CG: 17 | 1900–0700 | 1900–0700 | 0500, 0700 |
Horowitz 2001 | BL and fixed or free sleep | RL and fixed or free sleep | EG: 25 CG: 27 | 2300–0700 | 2300–0700, 0700–1100 | 2300–0700 |
Karchani 2011 | BLb | RL | EG: 45 CG: 45 | 2200, 2400, 0200 and 0400c | 0600–1400, 1400–2200, and 2200–0600 g | 2300, 0100, 0300, and 0500 |
Kretschmer 2013 | BL and RLa | RL | EG: 16 CG: 16 | 2200–0200, 2300–0300, 0000–0400c | 2200–0400f,h | Every 2 h/day |
Study | Illuminance (lux) | Treatment days | Tool | Outcome | ||
---|---|---|---|---|---|---|
Babkoff 2002 | E: 3000 C: 20–50 | 1 | VAS and RIA | Sleepiness and phase shift | ||
Bjorvatn 2007 | E: 10,000 C: 0 | 8 | KSS | Sleepiness | ||
Bjorvatn 2020 | E: 10,000 C: 100 | 3 | KSS | Sleepiness | ||
Boivin 2012 | NA | 7 | VAS and RIA | Sleepiness and phase shift | ||
Comtet 2019 | E: 10,000 C: 8 | 1 | KSS | Sleepiness | ||
Dawson 1991 | E: BL 6000 and DL 150–200 C: 150–200 | 3 | Core temperature | Phase shift | ||
Dawson 1995 | E: 4000–7000 C: 50 | 3 | RIA | Phase shift | ||
Griepentrog 2018 | E: 1500–2000 C: 300 | 1 | SSS and ELISA | Sleepiness and phase shift | ||
Horowitz 2001 | E: 2500 C: 150 | 3 | VAS and RIA | Sleepiness and phase shift | ||
Karchani 2011 | E: 2500–3000 C: 300 | 2 | SSS | Sleepiness | ||
Kretschmer 2013 | E: BL 3000 and RL 300 C: 300 | 3 | SSS | Sleepiness |
Study | Intervention treatment | Comparison treatment | Sample size (n) | Treatment period | Shift work period | Measure period |
---|---|---|---|---|---|---|
Lee 2006 | BL | DL | EG: 11 CG: 12 | 0045–0500 | 2300–0700 | Every 30 min at 1530–1200; 0000–1800 in last day |
Lee 2020 | BL | DL | EG: 12 CG: 12 | 0100–0600 | 0100–0600 | Every hour at 2100–0600 |
Lowden 2004 | BL | RL | EG: 18 CG: 18 | 1515–2145, 2145–0630, or 2400–0630 | 1515–2145, 2145–0630, and 2400–0630 | Every 2 h at 0000–0600, 0600–1400 |
Nagashima 2017 | BL | DL | EG: 12 CG: 12 | 1000–1600 | 0000–0800 | Every hour at 1800–0000 |
Sadeghniiat-Haghighi 2011 | BL | RL | EG: 47 CG: 47 | 0030–0050, 0230–0250 | 0600–1800, 1800–0600g | 2200, 2400, 0200, 0400 |
Smith 2009 | Intermittent BL pulse and RL | RL | EG: 9 CG: 10 | 0045–0400 | 2300–0700 | Every 30 min/day |
Sunde 2020 | BL | SL | EG: 36 CG: 36 | 2300–0500 | 2300–0700 | 2330, 0100, 0230, 0400, 0530 |
Tanaka 2011 | BL | No | EG: 61 CG: 61 | 0730–0800 | 0800–1700, and 1630–0830 | 1000, 1400 |
Thorne 2010 | WL and wearing sunglasses | No | EG: 10 CG: 10 | 1300–1400 | 1800–0600, or 1900–0700 | Every 4 h/day |
Yoon 2002 | BL | RL | EG: 12 CG: 12 | 0100–0500 and 0830–0930 | 2200–0800 | 4 times at 2400–0600 |
Study | Illuminance (lux) | Treatment days | Tool | Outcome | ||
---|---|---|---|---|---|---|
Lee 2006 | E: 3500 C: < 50 | 2 | RIA | Phase shift | ||
Lee 2020 | E: 430 C: < 1 | 1 | KSS and RIA | Sleepiness and phase shift | ||
Lowden 2004 | E: 2500 C: 300 | 15 | KSS and RIA | Sleepiness and phase shift | ||
Nagashima 2017 | E: > 3000 C: < 50 | 1 | RIA | Phase shift | ||
Sadeghniiat-Haghighi 2011 | E: 2500 C: 300 | 1 | SSS | Sleepiness | ||
Smith 2009 | E: 4100 C: < 50 | 8 | RIA | Phase shift | ||
Sunde 2020 | E: 900 C: 90 | 3 | KSS and ELISA | Sleepiness and phase shift | ||
Tanaka 2011 | E: 5444–8826 C: 0 | 30 | KSS | Sleepiness | ||
Thorne 2010 | E: 3000 C: 0 | 4 | RIA | Phase shift | ||
Yoon 2002 | E: NL 4000–6000 and SL 10,000 C: RL < 200 and SL 10,000 | 3 | VAS | Sleepiness |